chartbusters- 5th sept | muthoot fin, bel, sparc, sun pharma | cnbc tv18
Published 5 years ago • 621 plays • Length 23:54Download video MP4
Download video MP3
Similar videos
-
1:09
sp tulsian's views on muthoot finance | cnbc-tv18
-
0:32
muthoot microfin ipo: disappointing debut at 5.5% discount - stock lists at ₹275.30 | n18s
-
5:12
finstreet | q1fy25 performance review of banking sector | cnbc tv18
-
3:44
future of muthoot finance, united spirits | your stocks | cnbc tv18
-
19:40
sun pharma declines, sbi set to be big mover | chartbusters (10th aug) | cnbc tv18
-
1:36
sp tulsian on muthoot finance's gains of 7% | cnbctv18
-
5:13
sun pharma stocks stumble to 6 month low
-
13:16
valuations are worryingly high for some segments of the market: vetri subramaniam of uti asset mgmt
-
1:16
momentumisers: tracking the stock movement of muthoot finance | bazaar open exchange | cnbc-tv18
-
15:03
halftime report | muthoot finance falls 7% post q4 results | cnbc tv18
-
1:45
tata elxsi & tata tech surge. here’s why | cnbc tv18
-
9:44
aim for $15-20 m in terms of sales in the us in the next 3-5 years: poly medicure | cnbc tv18
-
1:02:41
market closing bell live | nifty flat; media outperforms, fmcg, metals drag | cnbc tv18
-
6:10
u.s. policy has been designed to keep foreign oil on the market, says rbc's helima croft
-
3:47
advise buyers not to keep positions open on gold prices, duties: karur vysya bank exec | cnbc tv18
-
1:25
sun pharma q1fy25: net profit, ebitda, margin beat est; us formulation sales at $466 m | cnbc tv18
-
5:37
stick to guidance of 20% topline growth & 26-27% ebitda margin in fy25: vinati organics | cnbc tv18
-
9:06
expect net interest margin to be at 4.5% for fy25: csb bank | cnbc tv18
-
3:16
cholamandalam investment replaces bajaj finance as the most expensive nbfc in india | cnbc tv18